Mounjaro is a new tablet recently introduced for the management of type 2 diabetes.
Mounjaro (tirzepatide) is a medication that has become available for adults living with type 2 diabetes. It works by mimicking the action of natural hormones in the body that help regulate blood sugar levels, contributing to better glucose control.
Who Can Take Mounjaro?
Guidelines suggest that Mounjaro can be considered for:
- Adults over the age of 18 years who have been diagnosed with type 2 diabetes.
When is Mounjaro Prescribed?
The National Institute for Health and Care Excellence (NICE) provides specific recommendations for when Mounjaro can be prescribed. It is generally considered in situations where:
- Existing treatments have not been effective: Mounjaro may be prescribed to adults with type 2 diabetes if using three other medications has not been sufficient in effectively managing their diabetes.
This targeted approach ensures that the medication is introduced where there is a clear medical need, particularly when other established therapies have not yielded the desired results for blood sugar control. For more detailed information on Mounjaro and its use in diabetes management, you can refer to reputable sources like those provided by Diabetes UK.
